rarely go into non US based companies because I fear of not being able to read their financials correctly <A HREF="http://www.astrazeneca.com/downloads/HY-2002-figures.pdf" target="_new">http://www.astrazeneca.com/downloads/HY-2002-figures.pdf</A> Pg 11 is where they is where they add back in crap goodwill and intangibles to "conform" with US GAAP. <vbg> I still think selloff in drug over pipeline and failed large molecule biologic drugs have been overdone.